US United States English
US Estados Unidos Español
PL Polska Polski
ZA South Africa English
ZA Suid-Afrika Afrikaans
United States English

Introducing the BTKi-SLE Study: a Systemic Lupus Erythematosus clinical research study

If you have SLE, and are between the ages of 18-75, consider taking part in the BTKi-SLE Study. Learn about the study or see if you may be eligible.

Living day in, day out with systemic lupus erythematosus (SLE) can be challenging. It takes courage and persistence. If you have SLE, could a clinical research study be an option for you?

The BTKi-SLE Study is a global clinical research study evaluating an investigational medication for people with SLE.

SLE is an autoimmune disease that can affect many parts of the body, including the skin, muscles and joints, and even organs located inside your body. This global study will be investigating the safety and effectiveness of an investigational medication in people with SLE. This global study will assess 3 doses of the investigational medication compared to placebo (a pill with no medicine in it).

Thank you for considering this clinical research study.

Learn more about this study

This website is supported by EMD Serono.